RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX): Price and Financial Metrics
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX)
Today's Latest Price: $23.37 USD
Updated Jul 2 7:00pm
Add RELX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 134 in Financial Services (Enterprise)
See all "A" rated Strong Buy stocks
RELX Stock Summary
- RELX has a market capitalization of $45,512,798,574 -- more than approximately 95.97% of US stocks.
- Of note is the ratio of Relx Plc's sales and general administrative expense to its total operating expenses; 87.54% of US stocks have a lower such ratio.
- In terms of volatility of its share price, RELX is more volatile than only 5.05% of stocks we're observing.
- Stocks that are quantitatively similar to RELX, based on their financial statements, market capitalization, and price volatility, are DG, PGR, SHW, KDP, and ITUB.
- Visit RELX's SEC page to see the company's official filings. To visit the company's web site, go to www.relx.com.
RELX Stock Price Chart Technical Analysis Charts
RELX Price/Volume Stats
| Current price | $23.37 | 52-week high | $27.25 |
| Prev. close | $23.65 | 52-week low | $16.81 |
| Day low | $23.30 | Volume | 1,904,199 |
| Day high | $23.46 | Avg. volume | 821,969 |
| 50-day MA | $23.20 | Dividend yield | 3.38% |
| 200-day MA | $23.67 | Market Cap | 45.37B |
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Company Bio
RELX PLC provides information solutions for professional customers in North America and Europe. The companys Scientific, Technical & Medical segment publishes research, reference, and education content; and offers database and workflow solutions for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations, and governments. The company was founded in 1894 and is based in London, United Kingdom.
RELX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $23.37 | $16.62 | -29% |
We started the process of determining a valid price forecast for Relx Plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Relx Plc ranked in the 39th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 28.83%. As for the metrics that stood out in our discounted cash flow analysis of Relx Plc, consider:
- RELX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 31.27% of tickers in our DCF set.
- Relative to other stocks in its sector (Consumer Cyclical), Relx Plc has a reliance on debt greater than only 14.71% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -31% |
| 1% | -30% |
| 2% | -29% |
| 3% | -28% |
| 4% | -28% |
| 5% | -27% |
ATR, DAN, DNKN, HZO, and PENN can be thought of as valuation peers to RELX, in the sense that they are in the Consumer Cyclical sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...